The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

Benzer Materyaller

• The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
  Yazar:: Vincent, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
  Yazar:: Vincent, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
  Yazar:: Levy, Howard, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis
  Yazar:: Laterre, Pierre-François, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis
  Yazar:: Wang, Shan, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)